Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: Systematic review and network meta-analysis

Background: Multiple targeted therapeutics are available for radioiodine-refractory differentiated thyroid cancer (RAIR-DTC), but it remains unclear which treatment is optimal to achieve long-term survival. Methods: A systematic search of the PubMed, Embase, and ClinicalTrials.gov databases was cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiaoyu, Liang, Weili, Lv, Guixu, Ding, Changyuan, Lai, Hong, Li, Luchuan, Zeng, Qingdong, Lv, Bin, Sheng, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461142/
https://www.ncbi.nlm.nih.gov/pubmed/36091770
http://dx.doi.org/10.3389/fphar.2022.933648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461142/
https://www.ncbi.nlm.nih.gov/pubmed/36091770
http://dx.doi.org/10.3389/fphar.2022.933648

Ejemplares similares